Active Not RecruitingNCT05905003
Predicting outcomes for people at clinical high risk of psychosis
About this title
Read the official source — NCT05905003Observational studyAges 12–30Multiple countriesSchizophrenia
Understand this study
Who could participate?
Listed age limits: 12 years to 30 years.
- Listed locations
- Irvine and 41 more locationsSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 2, 2022
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 2,617
- Sponsor
- Brigham and Women's Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- United States, Australia, Canada, ...
- Age range
- From 12 Years to 30 Years
- Official registry ID
- NCT05905003
- Official title
Show the full official title
Accelerating Medicines Partnership® Schizophrenia Observational Study: Psychosis Risk Evaluation, Data Integration, and Computational Technologies -Data Processing, Analysis, and Coordination Center and Coordination Center
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Irvine, United States · Los Angeles, United States · San Diego, United States
38 more locations
- San Francisco, United States
- Hartford, United States
- New Haven, United States
- Athens, United States
- Evanston, United States
- Boston, United States
- St Louis, United States
- New York, United States
- Queens, United States
- Chapel Hill, United States
- Eugene, United States
- Philadelphia, United States
- Pittsburgh, United States
- Adelaide, Australia
- Craigieburn, Australia
- Glenroy, Australia
- Melton South, Australia
- Parkville, Australia
- Sunshine, Australia
- Werribee, Australia
- Calgary, Canada
- Montreal, Canada
- Santiago, Chile
- Shanghai, China
- Copenhagen, Denmark
- Cologne, Germany
- Jena, Germany
- Munich, Germany
- Hong Kong, Hong Kong
- Pavia, Italy
- Singapore, Singapore
- Gwangju, South Korea
- Seoul, South Korea
- Madrid, Spain
- Lausanne, Switzerland
- Birmingham, United Kingdom
- Cambridge, United Kingdom
- London, United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Brigham and Women's Hospital, a hospital or academic medical center.
Who can participate?
Listed age limits: 12 years to 30 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
